Metraipolis › archive › dc_e24d8f5ed009
Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists — Europe PMC PMID:41938526
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41938526
- DOI
- 10.7150/ijms.131397
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T07:54:10.240Z
- SHA-256 of the archived text
b10767bf85aacd8810bbe0d386533a93ba17480fa5f22d0013b4fe16f9ebbc66- Stable URL of this page
https://metraipolis.com/documento/dc_e24d8f5ed009
How to cite
Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists — Europe PMC PMID:41938526 — Europe PMC (en), https://europepmc.org/article/MED/41938526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e24d8f5ed009 (Metraipolis archive dc_e24d8f5ed009, sha256 b10767bf85aacd8810bbe0d386533a93ba17480fa5f22d0013b4fe16f9ebbc66)
BibTeX
@misc{dce24d8f5ed009,
title = {Risk of peripheral vestibular disorders and hearing impairment among users of glucagon-like peptide-1 receptor agonists — Europe PMC PMID:41938526},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41938526},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e24d8f5ed009; sha256 b10767bf85aacd8810bbe0d386533a93ba17480fa5f22d0013b4fe16f9ebbc66},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41938526. Agents can read the archived copy with the MCP tool read_document.